Similarly, ADAMTS13-Act was significantly decreased in patients with overt infections or systemic inflammatory response syndrome, as compared to CTP-A patients [38] and ADAMTS13 antigen levels exhibited stepwise decline in patients with acute decompensation and acute-on-chronic liver failure, as compared to controls and stable cirrhosis [35]. The gene discussed is ADAMTS13; the disease is systemic inflammatory response syndrome.